Judit Hodrea

Budapest, BU 1083, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 11, 2025

UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation.

UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 09, 2025

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Journal: International journal of molecular sciences

Published: October 31, 2024

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells.

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells.

Journal: International journal of molecular sciences

Published: June 01, 2023

Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells.

Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells.

Journal: Life (Basel, Switzerland)

Published: April 13, 2023

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.

Journal: PloS one

Published: July 16, 2021

Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques.

Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques.

Journal: Amino acids

Published: August 26, 2020

Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney.

Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney.

Journal: American journal of physiology. Renal physiology

Published: March 03, 2020

Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition.

Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition.

Journal: Psychoneuroendocrinology

Published: January 29, 2020

Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling.

Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling.

Journal: Diabetologia

Published: November 27, 2018

RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.

RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.

Journal: The Journal of physiology

Published: August 16, 2018

The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury.

The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: February 16, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026